Skip to content
Tirzepatide Report
Provider review

Vital Edge Tirzepatide Review: Recurring Prices & Fee Questions

Researched & written by Alan PierceClinical Pharmacology WriterUpdated

On this page

Separate compounded injection, oral tirzepatide and branded programs with published recurring prices.

Standout details

  • Named compounded program publishes $450 initially then $450/month
  • Three-month bundle publishes $1,199 initially then every three months

Things to consider

  • Nonprescription $80 consultation footnote conflicts with enrollment approval-before-charge wording; clarify applicable fee
  • Exact cancellation cutoff, renewal authorization and preparation-stage refund agreement need confirmation

Vital Edge’s public program menu lists compounded tirzepatide at $450, then $450 per month, and a separate three-month bundle at $1,199, then $1,199 every three months. The bundle is a recurring three-month amount, not a $1,199 monthly bill or a confirmed monthly installment plan.3

Keep the named offers separate

The menu also lists oral tirzepatide at $269, then $269 per month, and Mounjaro at $835, then $835 per month. These are distinct offers. The oral product’s name and lower price do not establish the same clinical evidence as an injected brand medicine, and a compounded preparation is not the FDA-approved finished branded drug.3

Program cards advertise virtual physician consultation, home delivery and ongoing support. The site describes flat pricing without a dose-increase upcharge, while its cost FAQ says individual pricing depends on medication and dose. Confirm the selected formulation, amount supplied, services and recurring total rather than assuming one price applies to every possible prescription.3

Named program prices

SelectionPublished detail
Compounded tirzepatide$450 initially; then $450/month
Three-month bundle$1,199 initially; then $1,199 every three months
Oral tirzepatide$269 initially; then $269/month; evidence differs from injected brand treatment
Mounjaro$835 initially; then $835/month; separate branded offer
These are separate offers and published recurring intervals; clinical eligibility and the actual prescribed preparation remain individual decisions.3

Clarify the fee if medication is not prescribed

A footnote below the program menu says the telehealth consultation fee is $80 if medication is not prescribed. The enrollment landing instead says the card is not charged unless a prescription is approved, and describes payment processing after consultation approval. These statements leave an important fee question unresolved.3,4

Before providing payment authorization, ask whether the $80 fee applies after a nonprescribing consultation, what event authorizes it and how it relates to the approval-before-charge statement. Neither statement alone establishes a universal free consultation or full nonapproval refund.3,4

The OurView review provides a payment-timing comparison: its current FAQ says checkout authorizes payment, collection follows provider approval, and a declined treatment releases the authorization without a charge. That describes the initial approval process; it does not settle every later renewal or cancellation outcome. Ask for the fee and authorization rules governing the actual order.5

The public offers show recurring amounts, but a complete cancellation cutoff, automatic-renewal authorization and prescription refund agreement are not established by the pricing menu. Request the governing documents and ask what happens after a clinician reviews the intake, a prescription is written or the pharmacy begins preparation. Do not assume stopping future billing reverses an already processed prescription.3,4

Before payment

SelectionPublished detail
No prescriptionMenu footnote: $80 telehealth consultation fee
Card chargeEnrollment landing: no charge unless prescription approved
Cancellation / refundExact cutoff, renewal authorization and preparation-stage refund rules unconfirmed
Care / pharmacyConfirm treating practice, location eligibility and actual preparing/dispensing facility
The nonprescription fee footnote and approval-before-charge wording require clarification in the accepted agreement.3,4

Confirm the care and dispensing arrangements

Vital Edge describes local care in Chattanooga and virtual services, with email/text, video and phone consultation options. The enrollment landing begins with a personal-information form; it does not establish that video is mandatory, that a prescription will be issued or that a specific patient qualifies.3,4

Ask which clinical practice treats you, where it can provide care and which facility prepares and dispenses the actual prescription. A program name, product illustration or general approval claim does not verify current credentials, patient assignment or the exact ingredients and concentration of a compounded preparation.3

Brand-drug trials do not establish outcomes for this platform or its oral or compounded products. SURMOUNT-1 and SURMOUNT-5 provide clinical context, not proof of equivalence between these advertised options.1,2

Further reading

whether compounded tirzepatide is still legal in 2026, Zepbound side effects, the gallbladder risk, thyroid cancer warning, tirzepatide evidence guide, Vita Bella, Ondra Health, best tirzepatide providers.

Frequently asked questions

How much does Vital Edge’s compounded tirzepatide cost?

The public menu lists $450 initially and then $450/month, or $1,199 initially and then $1,199 every three months for the bundle. Confirm the selected prescription, quantity, services and total. Oral tirzepatide and branded Mounjaro are separate offers.

Is there a charge if medication is not prescribed?

The menu footnote says an $80 telehealth consultation fee applies if medication is not prescribed, while the enrollment landing says the card is not charged unless a prescription is approved. Ask which rule applies and what authorizes the fee before providing payment details.

What are the cancellation and pharmacy terms?

The program menu does not establish a complete cancellation cutoff or refund agreement after clinical review or medication preparation. Obtain the accepted recurring-payment terms and confirm the treating practice and actual preparing/dispensing facility; public descriptions do not establish assignment or current credentials.

References(5)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
  3. Vital Edge (2026). Homepage: named program prices, inclusions and nonprescription fee footnote. Vital Edge.
  4. Vital Edge (2026). Public enrollment landing: consultation and approval-before-charge statements. Vital Edge.
  5. OurView (2026). FAQ: payment, renewal, partners and availability. OurView.

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.